ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,002 | -16.4% | 3,132 | -5.3% | 0.00% | 0.0% |
| Q2 2023 | $101,719 | -24.6% | 3,309 | -11.6% | 0.00% | 0.0% |
| Q1 2023 | $134,860 | -10.8% | 3,743 | -2.2% | 0.00% | 0.0% |
| Q4 2022 | $151,204 | -2.4% | 3,826 | -0.6% | 0.00% | 0.0% |
| Q3 2022 | $155,000 | -3.7% | 3,851 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $161,000 | -18.3% | 3,841 | -23.9% | 0.00% | 0.0% |
| Q1 2022 | $197,000 | -2.5% | 5,044 | -0.7% | 0.00% | 0.0% |
| Q4 2021 | $202,000 | +6.3% | 5,080 | -3.4% | 0.00% | 0.0% |
| Q3 2021 | $190,000 | -19.1% | 5,259 | -8.2% | 0.00% | 0.0% |
| Q2 2021 | $235,000 | +2.2% | 5,727 | +8.7% | 0.00% | 0.0% |
| Q1 2021 | $230,000 | +132.3% | 5,270 | +166.8% | 0.00% | – |
| Q4 2020 | $99,000 | +47.8% | 1,975 | +24.4% | 0.00% | – |
| Q3 2020 | $67,000 | – | 1,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |